skip to main content

HRA-19a1.1 Alpha2Alpha1 B

HRA-19a1.1 Alpha2Alpha1 B

Catalogue No.

09071524

Cell Line Name

HRA-19a1.1 Alpha2Alpha1 B

Cell Line Description

Genetically modified HRA-19a1.1 cells (ECACC Catalogue number 09071517) expressing a chimeric alpha2 integrin with the extracellular and transmembrane domain of alpha2 integrin and the cytoplasmic domain of alpha1 integrin

General Info

Species

Human

Release Conditions

Restricted - commercial organisations are required to complete the 'Cell Line Release Authorisation for Research Use in Commercial Organisations' release conditions form in the supporting documents section.

Characteristics

Receptors

Not specified

Products

Not specified

Tissue of Origin

Rectum

DNA profile (STR Profile)

Amelogenin: X,Y
CSF1PO: 12
D5S818: 11
D7S820: 9,12
D13S317: 11,12
D16S539: 11
TH01: 8
TPOX: 11
vWA: 16

Karyotype

Not specified

Applications

Role of Alpha 2 integrin in colon epithelial biology

Disease

Adenocarcinoma

Culture Conditions

Cell Type

Epithelial

Subculture Routine

Split sub-confluent cultures (70-80%) 1:3 to 1:4 weekly using 0.0125% trypsin/EDTA; 7.5% CO₂; 37°C. Suggested seeding density 2-4x10,000 cells/cm².

Culture Medium

DMEM (High glucose Sigma D6546) + 2mM Glutamine + 10% Foetal Bovine Serum (FBS) + G418 200µg/ml

Growth Mode

Adherent

Additional Info

Depositor

Dr S Kirkland, Department of Histopathology, Imperial College London, Hammersmith Campus, DuCane Road London W12 0NN

Country of Origin

United Kingdom

GMO Status

Genetically Modified Organism Class 1 (GMO1)

Hazard Group (ACDP)

Hazard Group (ACDP) 2

Applications

References

Kirkland & Bailey 1986 Establishment and characterisation of six human colorectal adenocarcinoma cell lines. Br J Cancer 53: 779-785. PMID: 3718830. Kirkland 1986 Endocrine differentiation by a human rectal adenocarcinoma cell line (HRA-19). Differentiation 33: 148-155. PMID: 3569697.

Bibliography

Kirkland S C 1988 Clonal origin of columnar, mucous and endocrine cell lineages in human colorectal epithelium. Cancer 61: 1359-1363. PMID: 2449944. Kirkland & Ying 2008 Alpha2 beta1 Integrin regulates lineage commitment in multipotent human colorectal cancer cells. Journal of Biological Chemistry 283: 27612-27619. PMID: 18664572. Henderson & Kirkland 1996 Multilineage differentiation of cloned HRA-19 cells in serum free medium. A model of human colorectal epithelial differentiation. Differentiation 60: 259-268. PMID: 8765056.

Available Formats

  • Frozen

If use of this culture results in a scientific publication, it should be cited in the publication as: HRA-19a1.1 Alpha2Alpha1 B (ECACC 09071524).

Unless specified otherwise, at ECACC we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines (Advisory Committee on Dangerous Pathogens) (UK). All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country. ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.